Symbol="ANAB"
AssetType="Common Stock"
Name="AnaptysBio Inc"
Description="AnaptysBio, Inc., a clinical-stage biotechnology company, is dedicated to developing therapeutic product candidates for inflammation and immuno-oncology indications. The company is headquartered in San Diego, California."
CIK="1370053"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="10421 PACIFIC CENTER COURT, SUITE 200, SAN DIEGO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="521268000"
EBITDA="-139471008"
PERatio="None"
PEGRatio="0"
BookValue="5.59"
DividendPerShare="0"
DividendYield="0"
EPS="-4.7"
RevenuePerShareTTM="0.465"
ProfitMargin="0"
OperatingMarginTTM="-10.83"
ReturnOnAssetsTTM="-0.156"
ReturnOnEquityTTM="-0.636"
RevenueTTM="12935000"
GrossProfitTTM="-78511000"
DilutedEPSTTM="-4.7"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="1.845"
AnalystTargetPrice="29.75"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="178.16"
PriceToBookRatio="3.005"
EVToRevenue="91.55"
EVToEBITDA="-3.592"
Beta="-0.138"
num_52WeekHigh="32.44"
num_52WeekLow="16.66"
num_50DayMovingAverage="19.13"
num_200DayMovingAverage="23.13"
SharesOutstanding="26487200"
DividendDate="None"
ExDividendDate="None"
symbol="ANAB"
open="19.04"
high="19.75"
low="19.04"
price="19.61"
volume="326019.00"
latest_trading_day="2023-08-18"
previous_close="19.25"
change="0.36"
change_percent="1.8701%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="100"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="0"
Volume_recent_avg="228088"
Change_recent_avg="-0.06"
Delta_recent_avg="0.92"
Variance_recent_avg="0.46"
Change_ratio_recent_avg="-0.33"
RSI_change="FALSE"
ADX_change="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="0"
Aroon_momentum_negative="100"
image_negative_thumbnail_id_1="168"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0008.jpeg"
image_negative_thumbnail_id_2="1165"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0199.jpeg"
image_neutral_thumbnail_id_1="563"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0036.jpeg"
image_neutral_thumbnail_id_2="532"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0067.jpeg"
image_positive_thumbnail_id_1="949"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0111.jpeg"
image_positive_thumbnail_id_2="663"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0045.jpeg"
image_professor_thumbnail_id_1="1192"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0026.jpeg"
image_professor_thumbnail_id_2="1176"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0010.jpeg"
